Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$107,118,870
+$20,791,870 QoQ
Shares Held
425,683
+7.2% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#245
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026&PARTNERS holds $840,453,680 across 15 Drug Manufacturers - General names. ABBV ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
180,745 | $216,790,993 | |
| 2 | JNJ |
Johnson & Johnson
|
809,873 | $205,683,445 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
425,683 | $107,118,870 | |
| 4 | AMGN |
Amgen Inc
|
280,838 | $101,697,056 | |
| 5 | MRK |
Merck & Co., Inc.
|
562,388 | $72,266,858 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
403,145 | $50,933,339 | |
| 7 | NVS |
Novartis AG
|
147,424 | $23,104,289 | |
| 8 | AZN |
Astrazeneca PLC
|
99,983 | $18,958,776 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,118,870 | 425,683 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $86,327,000 | 396,924 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $87,392,855 | 382,480 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $70,960,989 | 306,474 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,754,874 | 284,209 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,918,310 | 233,478 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,091,676 | 208,732 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,579,309 | 119,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,682,076 | 38,958 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,692,894 | 14,788 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,277,572 | 8,244 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $847,704 | 5,687 | Shares | Sole | 2023-10-06 | |
| 2023-06-30 | $757,317 | 5,621 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $833,983 | 5,233 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $865,421 | 5,355 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $724,599 | 5,399 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $846,821 | 5,529 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $880,257 | 5,430 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $436,394 | 3,223 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $398,903 | 3,698 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $394,014 | 3,498 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $297,929 | 2,753 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $305,698 | 2,853 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $249,894 | 2,853 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $231,017 | 2,353 | Shares | Sole | 2020-07-07 | |
| No filing history on record for this holder in this stock. | ||||||